CollPlant Biotechnologies (CLGN) Enterprise Value (QoQ) (2018 - 2024)
CollPlant Biotechnologies (CLGN) Enterprise Value (QoQ) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.38% |
| Sep 30, 2024 | -1,238.33% |
| Jun 30, 2024 | 92.79% |
| Mar 31, 2024 | -887.09% |
| Dec 31, 2023 | 89.44% |
| Sep 30, 2023 | -1,028.08% |
| Jun 30, 2023 | 24.92% |
| Mar 31, 2023 | 86.18% |
| Dec 31, 2022 | -560.19% |
| Sep 30, 2022 | 10.06% |
| Jun 30, 2022 | 11.59% |
| Mar 31, 2022 | 99.98% |
| Dec 31, 2021 | -813,610.55% |
| Sep 30, 2021 | -46.63% |
| Jun 30, 2021 | 90.79% |
| Mar 31, 2021 | -5,130.91% |
| Dec 31, 2020 | 31.17% |
| Sep 30, 2020 | -34.05% |
| Jun 30, 2020 | 32.48% |
| Mar 31, 2020 | 96.54% |